Diagnostic marker of inferior myocardial infarction and/or anterior myocardial infarction
A myocardial infarction and marker technology, applied in the fields of molecular biology and medical diagnosis, can solve the problem of low sensitivity and achieve the effect of less harm to patients, strong specificity and convenient operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 2
[0098] Example 2 The diagnostic effect of lysophosphatidylcholines
[0099] 1. Draw the ROC curve and analyze the effect of four lysophosphatidylcholine substances, including LysoPC(14:0), LysoPC(15:0), LysoPC(17:0) and LysoPC(18:0) on the different incidence of myocardial infarction The precise diagnostic value of the site. The results of comparison between the anterior wall myocardial infarction group and the inferior wall myocardial infarction group showed that the diagnostic AUC of LysoPC(14:0) was 0.812 (95%CI); the diagnostic AUC of LysoPC(15:0) was 0.757 (95%CI); The diagnostic AUC of LysoPC(17:0) is 0.747 (95%CI); the diagnostic AUC of LysoPC(18:0) is 0.724 (95%CI), the results can be found in Figure 1-Figure 4 .
[0100] The results of comparison between the healthy control group and the anterior myocardial infarction group showed that the diagnostic AUC of LysoPC(14:0) was 0.678 (95%CI); the diagnostic AUC of LysoPC(15:0) was 1.000 (95%CI); 17:0) diagnostic AUC i...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com